Effects of the early administration of Zofenopril on onset and progression of congestive heart failure in patients with anterior wall acute myocardial infarction

American Journal of Cardiology

Volumn 78, Issue 3, 1996, Pages 317-322

  Borghi, Claudio ^a,b   Ambrosioni, Ettore ^a   Magnani, Bruno ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Clinica Medica 3   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; NITRATE; PLACEBO; VASODILATOR AGENT; ZOFENOPRIL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0030221223     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00285-8     Document Type: Article

References (18)

1. Borghi C, Bacchelli S, Degli Esposti D, Ambrosioni E Early and late angiotensin-converting-enzyme inhibition in acute myocardial infarction. Am J Cardiol. 72:1993;169G-174G.
2. Swedberg K, Held P, Kiekshus J, Rasmussen K, Ryden L, Wedel H, on behalf of the CONSENSUS II Study group. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med 1992;327:678-684.
3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico GISSI 3 Effects of lisinopril and transdermal glyceril trinitrate and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 343:1994;1115-1122.
4. ISIS 4 Collaborative Group ISIS 4: a randomized factorial trial assessing early oral captopril, oral mononitrates, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 345:1995;669-682.
5. Pye M, Oldroyd KG, Ray SG, Christie J. Ford I, Cobbe SM, Dargie HJ. Effects of early captopril administration on left ventricular dilatation after acute myocardial infarction (abstr). Circulation 1990;82(suppl III):III-674.
6. Stone PH, Raabe DS, Jaffe AS, Gustafson N, Muller JE, Turi ZG, Rutherford JD, Poole KW, Passamani E, Willerson JT, Sobel BE, Robertson T, Braunwald E, for the MILIS Group. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol 1988;11:453-46.
7. Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-Term Evaluation Study Investigators. The effects of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995;332:80-85.
8. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS 1. Lancet. 2:1988;349-360.
9. Gruppo Italiano per lo Studio della Streptokinasi nell'Infarto (GISSI) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet. 1:1986;397-402.
10. DeForrest JM, Waldron TL, Krapcho J, Turk C, Rubin B, Powell JR, Cushman DW, Petrillo EW Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzyme. J Cardiovasc Pharmacol. 13:1989;887-894.
11. Cushman DW, Wang FL, Fung WC, Harvey CM, DeForrest JM Differentiation of angiotensin converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. Am J Hypertens. 2:1989;294-307.
12. Ambrosioni E, Borghi C, Magnani B, for the SMILE Pilot Study Working Party. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. Am J Cardiol 1991;68:101D-110D.
13. Van Gilst WH, Scholtens E, De Graeff PA, De Langen CDJ, Wesseling H Differential influences of angiotensin converting enzyme inhibitors on the coronary circulation. Circulation. 77(suppl I):1988;1-24.
14. Westlin W, Mullane K Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation. 71(suppl I):1984;I-30-I-39.
15. Ambrosioni E, Borghi C, Magnani B. Survival of Myocardial Infarction Long term Evaluation (SMILE) study: rationale, design, organization and outcome definitions. Controlled Clin Trials 1994;15:201-210.
16. Madsen EB, Gilpin E, Slutsky RA, Ahnve S, Henning H, Ross J Jr. Usefulness of chest x-ray for predicting abnormal left ventricular function after acute myocardial infarction. Am Heart J. 108:1984;1431-1436.
17. Pfeffer MA, Braunwald E, Moyè LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 327:1992;669-677.
18. The SOLVD Investigators Effects of enalapril on mortality and development of heart failure in asymptomatic patients with reduced ventricular ejection fraction. N Engl J Med. 327:1992;685-691.